GEODE CAPITAL MANAGEMENT, LLC - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 13 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$534,000
+907.5%
237,477
+1502.1%
0.00%
Q2 2021$53,000
-27.4%
14,8230.0%0.00%
Q1 2021$73,000
+17.7%
14,823
+17.1%
0.00%
Q4 2020$62,000
-54.7%
12,656
-63.9%
0.00%
Q3 2020$137,000
-18.5%
35,030
+0.6%
0.00%
Q2 2020$168,000
-6.1%
34,838
+1.1%
0.00%
Q1 2020$179,000
-73.4%
34,454
-48.9%
0.00%
Q4 2019$674,00067,3720.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,815,500$8,950,0000.30%
Sterling Financial Planning, Inc. 1,171$6,0000.01%
UBS Group AG 3,991$20,0000.00%
OSAIC HOLDINGS, INC. 468$2,0000.00%
US BANCORP \DE\ 2,710$13,0000.00%
WELLS FARGO & COMPANY/MN 34$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,656$62,0000.00%
North Star Investment Management Corp. 20$00.00%
MORGAN STANLEY 466$2,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders